These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7223616)

  • 1. Oral vasodilator therapy with prazosin in severe congestive heart failure.
    Awan NA; Mason DT
    Am Heart J; 1981 May; 101(5):695-700. PubMed ID: 7223616
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography.
    Awan NA; Miller RR; DeMaria AN; Maxwell KS; Neumann A; Mason DT
    Circulation; 1977 Sep; 56(3):346-54. PubMed ID: 884789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasodilator therapy--a physiologic approach to the treatment of heart failure.
    Braunwald E
    N Engl J Med; 1977 Aug; 297(6):331-3. PubMed ID: 876316
    [No Abstract]   [Full Text] [Related]  

  • 4. Ambulatory prazosin treatment of chronic congestive heart failure: development of late tolerance reversible by higher dosage and interrupted substitution therapy.
    Awan NA; Lee G; DeMaria AN; Mason DT
    Am Heart J; 1981 May; 101(5):541-7. PubMed ID: 7223594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective.
    Awan NA; Needham KE; Evenson MK; Amsterdam EE; Mason DT
    Am J Med; 1981 Jul; 71(1):153-60. PubMed ID: 7246573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vasodilator therapy with alpha-receptor blockaders. Acute and chronic effect of prazosin and phentolamine in congestive heart failure].
    Kersting F; Samosny G; Kasper W; Schuster HP
    Med Welt; 1981 Jun; 32(26):1040-5. PubMed ID: 6114383
    [No Abstract]   [Full Text] [Related]  

  • 7. Vasodilator therapy in congestive heart failure.
    Mason DT
    Ann Acad Med Singap; 1981 Oct; 10(4 Suppl):36-42. PubMed ID: 7344600
    [No Abstract]   [Full Text] [Related]  

  • 8. Sustained effectiveness of chronic prazosin therapy in severe chronic congestive heart failure.
    Bertel O; Burkart F; Bühler FR
    Am Heart J; 1981 May; 101(5):529-33. PubMed ID: 7223592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The acute and chronic haemodynamic effects of prazosin in severe congestive cardiac failure.
    Harper RW; Claxton H; Middlebrook K; Anderson S; Pitt A
    Med J Aust; 1980 Jul; 2(SP1):36-8. PubMed ID: 7421721
    [No Abstract]   [Full Text] [Related]  

  • 10. [Usefulness of vasodilators in congestive cardiac insufficiency: studies with prazosin].
    Conti CR; Miles D; Mehta J
    Cardiology; 1980; 66 Suppl 2():186-92. PubMed ID: 7285029
    [No Abstract]   [Full Text] [Related]  

  • 11. Importance of neuroendocrine regulators of vascular tone and integral adrenoreceptor interaction during oral vasodilator therapy of severe congestive heart failure with prazosin.
    Awan NA; Beattie JM; Evenson ME; Needham KE; Mason DT
    J Cardiovasc Pharmacol; 1982; 4 Suppl 1():S176-80. PubMed ID: 6175836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of vasodilator agents in chronic heart failure].
    Bussmann WD
    Med Klin; 1981 Apr; 76(9):249-53. PubMed ID: 6456408
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of pharmacodynamic tolerance to prozosin in congestive heart failure.
    Desch CE; Magorien RD; Triffon DW; Blanford MF; Unverferth DV; Leier CV
    Am J Cardiol; 1979 Nov; 44(6):1178-82. PubMed ID: 495512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congestive cardiomyopathy: therapeutic approach.
    Chatterjee K; Stern L
    Compr Ther; 1982 Jul; 8(7):25-34. PubMed ID: 7116806
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acute myocardial infarction with pump failure: hemodynamic response to prazosin].
    Oliveri R; Cremades E; Bazzino O; Doval H
    Cardiology; 1980; 66 Suppl 2():193-201. PubMed ID: 7285030
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of oral prazosin therapy on exercise hemodynamics in patients with severe chronic heart failure.
    Chatterjee K; Rubin SA; Ports TA; Parmley WW
    Am J Med; 1981 Jul; 71(1):140-6. PubMed ID: 7246571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symposium on Congestive Heart Failure. Introduction.
    Conti CR
    Am J Med; 1981 Jul; 71(1):131-4. PubMed ID: 7246570
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vasodilator therapy of congestive heart failure: comparison of hemodynamic effects after administration of nitroprusside i.v. and oral prazosin (author's transl)].
    Mauri F; Gronda E; Bossi M; Rovelli F
    G Ital Cardiol; 1980; 10(4):414-23. PubMed ID: 7439582
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chronic vasodilator treatment in heart failure. II. Prazosin therapy].
    Costică II; Dumitriu M; Cinteză M; Dăescu L; Bălan C
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(5):397-403. PubMed ID: 6151226
    [No Abstract]   [Full Text] [Related]  

  • 20. Vasodilator therapy of chronic congestive heart failure.
    Cabaniss CD
    J Med Assoc Ga; 1980 Feb; 69(2):131-2. PubMed ID: 7373170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.